Ignite Creation Date:
2024-05-06 @ 3:11 PM
Last Modification Date:
2024-10-26 @ 1:44 PM
Study NCT ID:
NCT04547062
Status:
COMPLETED
Last Update Posted:
2023-04-28
First Post:
2020-09-04
Brief Title:
Monocentric Phase 1 Study With Escalation of Doses of Tocilizumab in Combination With Chemotherapy Idarubicin and Cytarabine in Patients With Acute Myeloblastic Leukemia AML
Sponsor:
Organization:
Nantes University Hospital
Study Design
Study Type:
INTERVENTIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
None
Target Duration:
None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
None
Bio Spec Description:
None
Enrollment Count:
12
Enrollment Type:
ACTUAL
Design Primary Purpose:
Design Masking:
Phases:
| Name |
|---|
| PHASE1 |
Observational Models:
Time Perspective List:
Who Masked List: